Delivery Order SPE2DR25D3504-SPE2DR26F7BL2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance based in Conshohocken, Pennsylvania and an ultimate completion date of December 26, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,579.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) with a ceiling value of $1,792.50. The contract, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccines (12 years and up) in 0.5ml syringes, with a completion date of January 2, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.50 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order was issued on November 5, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine vaccine procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.65 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,632.00 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (12 years and up), 0.5 milliliter syringes. The contract is a firm fixed-price delivery order with no set-aside designation, awarded on December 11, 2025, with an ultimate completion date of January 5, 2026. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BL2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,579.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringe format, with completion targeted for December 26, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction executed on December 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for federal military and veteran healthcare systems through its extensive portfolio of delivery orders. The company's federal contracting activity demonstrates its capability to meet Defense Logistics Agency requirements across a broad spectrum of pharmaceutical products, including vaccines, specialty medications, and medical supplies for multiple therapeutic domains. This specific delivery order for Spikevax vaccine supports the Defense Health Agency and other government healthcare system vaccination initiatives while leveraging the established prime vendor relationship that enables flexible and rapid fulfillment of federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/3/25 |